Unravel the complexities of genetic research in neurodegenerative movement disorders. This track examines the fundamental genetic underpinnings of parkinson’s, huntington’s, and other conditions, with a focus on how genetics influences disease development and progression. Explore innovative therapeutic approaches, including gene-editing technologies like crispr, and the potential of gene therapies to modify disease outcomes. Ethical concerns surrounding genetic manipulation and testing will also be a key discussion point
Track 1-1: Genetic Mechanisms In Parkinson’s Disease
Track 1-2: Huntington’s Disease And Genetic Mutations
Track 1-3: Genomic Tools For Disease Diagnosis
Track 1-4: CRISPR And Gene Editing In Movement Disorders
Track 1-5: Ethical Considerations In Genetic Research
Delve into the latest research on genetic mechanisms, diagnostic tools, and the ethical challenges surrounding genetic manipulation, offering a deeper understanding of how genetic insights can pave the way for novel treatments.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
